1-3 of 3
Rik Schots, MD, PhD
Close
Sort by
Journal Articles

Long-Term Survival and Quality of Life Analysis after Autologous Stem Cell Transplantation for Lymphoma

Sylvia Faict, MD, Nathan De Beule, MD, Ann De Becker, MD, Karel Fostier, MD, Fabienne Trullemans, MD, Henri (Rik) Schots, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2268.
https://doi.org/10.1182/blood.V128.22.2268.2268
Published: 2016
Journal Articles

Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation

Karel Fostier, MD, Jurgen Corthals, Carlo Heirman, Joeri L. Aerts, PhD, Kris Thielemans, MD, PhD, Rik Schots, MD, PhD, Brenda De Keersmaecker, PhD
Journal: Blood
Blood (2013) 122 (21): 3214.
https://doi.org/10.1182/blood.V122.21.3214.3214
Published: 2013
Journal Articles

Outcomes Of Allogeneic Cord Blood Transplantation For Leukodystrophies; A Joint Study of Eurocord and “Inborn Errors WP-EBMT”

Hol Janna, Annalisa Ruggeri, MD, Vanderson Rocha, MD, Gerard Michel, Mouhab Ayas, MD, Tracey O'Brien, Gergely Krivan, Bordon Victoria, Rik Schots, MD, PhD, Rovelli Attilio, Elorza Izaskun, Jose M Moraleda, Peter J. Shaw, MBBS, MA, Marleen Renard, Karl-Walter Sykora, MD, Reuven Or, MD, Tsila Zuckerman, MD, Manuel Abecasis, Bredius Robbert, M. Akif Yesilipek, Miguel Angel Diaz, MD, PhD, Gennery Andy, Eliane Gluckman, MD, Jaap Jan Boelens, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2101.
https://doi.org/10.1182/blood.V122.21.2101.2101
Published: 2013